Ambulatory Adaptation to Non-Invasive Mechanical Ventilation

NCT ID: NCT00698958

Last Updated: 2008-06-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomised study to assess the effectiveness of ambulatory adaptation to non-invasive mechanical ventilation in patient with hypercapnic respiratory failure secondary to neuromuscular diseases or alterations in thoracic cage in comparison with hospital adaptation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Respiratory Failure

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Respiratory insufficiency Hypercapnic chronic respiratory failure secondary to neuromuscular diseases or alterations of thoracic cage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Hospital based adaptation to non- invasive mechanical ventilation for 7 days

Group Type ACTIVE_COMPARATOR

Hospital based adaptation to non- invasive mechanical ventilation for 7 days

Intervention Type PROCEDURE

Hospital based adaptation to non- invasive mechanical ventilation for 7 days

2

Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

Group Type EXPERIMENTAL

Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

Intervention Type PROCEDURE

Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

Ambulatory adaptation to non- invasive mechanical ventilation for 7 days

Intervention Type PROCEDURE

Hospital based adaptation to non- invasive mechanical ventilation for 7 days

Hospital based adaptation to non- invasive mechanical ventilation for 7 days

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age between 18 and 75
2. Chronic respiratory insufficiency secondary to neuromuscular disease or thoracic cage alterations with indication of non-invasive mechanical ventilation (presence of fatigue, dyspnea, morning headache, etc) plus one of the following criteria):

* PaCO2 \> 45 mmHg
* Night time oxygen saturation \< 88% at least for 5 consecutive minutes
* In neuromuscular diseases, PIM \< 60 cmH2O or FVC \< 50% of theoretical.
3. Stable disease.
4. Airway access through nasal mask.
5. Ability to provide written informed consent.
6. Ability to attend the visits

Exclusion Criteria

1. Contraindications for mechanical ventilation:

* Patient with terminal disease or vegetative state
* Lack of motivation of the patient
* Lack of family or social support
* Patients clinically unstable
* Agitation or lack of co-operation
* Depression.
2. Patients with acute symptoms requiring hospital admission.
3. Need for airway access through tracheostomy, face mask or mouth piece.
4. Relevant comorbidity (ie. heart failure, diabetes non controlled, infections, malignancies, etc.) leading to difficulties in adaptation to ventilation.
5. Use (for 7 days or more) of CNS depressors(benzodiazepines, antihistamines H1, tricyclic antidepressants , antiepileptic or antipsychotic drugs ) in the 30-day period prior to inclusion, or expected need for such drugs during the study.
6. Lack of understanding of the study procedures.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitari Vall d'Hebron Research Institute

OTHER

Sponsor Role collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

Sponsor Role collaborator

Hospital Clinic of Barcelona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hospitals Vall d'Hebron

References

Explore related publications, articles, or registry entries linked to this study.

Pallero M, Puy C, Guell R, Pontes C, Marti S, Torres F, Anton A, Munoz X. Ambulatory adaptation to noninvasive ventilation in restrictive pulmonary disease: a randomized trial with cost assessment. Respir Med. 2014 Jul;108(7):1014-22. doi: 10.1016/j.rmed.2014.04.016. Epub 2014 May 2.

Reference Type DERIVED
PMID: 24837977 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NEUMO/2002/01

Identifier Type: -

Identifier Source: org_study_id